Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(20%)

Results Posted

25%(1 trials)

Phase Distribution

Ph not_applicable

80%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

N/ANon-phased studies

4(80.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Detailed Status

Completed4

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (20.0%)

N/A4 (80.0%)

Trials by Status

active_not_recruiting120%

completed480%

Recent Activity

1 active trials

Showing 5 of 5

active_not_recruitingnot_applicable

Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder

NCT04712981

completednot_applicable

Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts From Brain Death Donors

NCT03378817

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT04712981Not Applicable

Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder

Active Not Recruiting

NCT03378817Not Applicable

Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts From Brain Death Donors

Completed

NCT02398227Not Applicable

Treatment of PTSD in Residents of Battered Women's Shelters

Completed

NCT01670708Not Applicable

HOPE Demonstration Field Experiment Multisite Evaluation

Completed

NCT01240408Phase 1

E7080 Food Effect Study in Healthy Subjects

Completed

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5